Ovid Therapeutics Inc. OVID
- OV329 — Drug-Resistant Focal Onset Seizures Phase 2
- OV329 — Tuberous Sclerosis Complex Preclinical
- OV329 — Infantile Spasms Preclinical
GABA-AT (1 companies · 3 programs)
Companies with an active program directed at GABA-AT.